Agios Pharmaceuticals Inc Revenue per Employee (AGIO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Agios Pharmaceuticals Inc   (NASDAQ: AGIO)
 

Agios Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 137.75% in the first quarter 2026, year on year to cumulative value of $66 million, Agios Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 122,311, this is below the company average.
Within the Healthcare sector Employees of 71 other companies have achieved higher revenue per employee. While Agios Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 614 to 804. Agios Pharmaceuticals Inc has 540 employees.


What is Sales per Employee Ratio?







AGIO Revenue per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Revenue Change 137.75 % 86.09 % 43.69 % 44.57 % 6.56 %
Sales per Employee (TTM) $ 122,311 100,052 82,946 75,694 68,583
AGIO's Total Ranking # 804 # 614 # 2771 # 2126 # 1550
Seq. Revenue Change 3.9 % 55.02 % 3.41 % 42.73 % -18.68 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 23
Healthcare Sector # 72
Overall Market # 804

Revenue per Employee Statistics
High Average Low
$ 376,289 $ 131,708 $ 26,370
(Dec 31 2020)   (Dec 31 2022)



Financial Statements
Agios Pharmaceuticals Inc 's Revenue MRQ $ 21 Millions Visit AGIO's Income Statement
Agios Pharmaceuticals Inc 's Revenues TTM $ 66 Millions Visit AGIO's aggregate revenue growth
What are AGIO's Sales? Visit AGIO's Sales by Segment




Other Ratios
Agios Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AGIO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AGIO's Competitors
Revenue per Employee for AGIO's Suppliers
Revenue per Employee for AGIO's Customers

You may also want to know
AGIO's Sales Growth Rates AGIO's Pe Price to earnings ratio AGIO's Receivables Turnover Ratio AGIO's Stock Quote
AGIO's Net Income Growth Rates AGIO's Ps Price to Sales ratio AGIO's Sales per Employee AGIO's Asset Turnover Ratio
AGIO's Net Margin AGIO's Pb Price to Book ratio AGIO's Financial Strength Ratios AGIO's Dividend Payout Ratio
Date modified: 2026-09-08T15:55:07+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Myomo Inc   211,181.03 $ 41.180  Million 195 
Viemed Healthcare Inc   207,355.28 $ 286.565  Million 1,382 
Pacific Health Care Organization Inc  206,262.10 $ 6.394  Million 31 
Merit Medical Systems Inc  205,606.27 $ 1,542.047  Million 7,500 
Charles River Laboratories International inc   204,418.48 $ 4,027.044  Million 19,700 
Immunitybio inc   204,018.81 $ 140.977  Million 691 
Fonar Corporation  202,573.69 $ 105.338  Million 520 
Labcorp Holdings Inc   202,060.00 $ 14,144.200  Million 70,000 
Align Technology inc   201,798.52 $ 4,094.492  Million 20,290 
Utah Medical Products Inc  200,792.35 $ 36.745  Million 183 
X4 Pharmaceuticals Inc  200,311.11 $ 9.014  Million 45 
Meiragtx Holdings Plc  197,910.67 $ 79.758  Million 403 
Quest Diagnostics Inc  197,859.65 $ 11,278.000  Million 57,000 
Precigen Inc   197,468.75 $ 31.595  Million 160 
Rapid Micro Biosystems Inc   197,385.96 $ 33.753  Million 171 
Sbc Medical Group Holdings Incorporated  194,131.63 $ 167.536  Million 863 
Lineage Cell Therapeutics Inc   191,935.06 $ 14.779  Million 77 
Fortrea Holdings Inc   189,412.59 $ 2,708.600  Million 14,300 
Gyre Therapeutics Inc   189,399.68 $ 117.049  Million 618 
Stoke Therapeutics Inc   188,705.88 $ 32.080  Million 170 
Hcw Biologics Inc   188,344.31 $ 6.592  Million 35 
Metagenomi Therapeutics Inc   187,655.46 $ 22.331  Million 119 
Humacyte Inc   186,826.09 $ 34.376  Million 184 
Plus Therapeutics Inc   185,071.43 $ 5.182  Million 28 
Retractable Technologies Inc  179,999.94 $ 36.180  Million 201 
Iqvia Holdings Inc   178,838.71 $ 16,632.000  Million 93,000 
Alector Inc   178,805.83 $ 18.417  Million 103 
Vir Biotechnology Inc   178,460.49 $ 65.495  Million 367 
Neuraxis Inc   178,396.25 $ 4.282  Million 24 
Prophase Labs Inc   178,210.53 $ 3.386  Million 19 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.